(Total Views: 578)
Posted On: 12/11/2020 12:07:22 PM
Post# of 153831
“No new test needs to be developed.”
Please follow the link below to the CYDY PR about the RO test for leronlimab that Incelldx developed. That is a proprietary assay. If CYDY chooses to use a different lab, that lab will have to develop a new RO test for leronlimab. Those are facts.
https://www.cytodyn.com/investors/news-events...-occupancy
“They would need to use stored samples from the trial. You're starting to talk like justdafactss.”
Again, I’d place a very large wager that CYDY does not have the banked samples from the trials. This is a good question for the next CC, although it may not matter because COVID approval will make the combo BLA somewhat irrelevant.
Please follow the link below to the CYDY PR about the RO test for leronlimab that Incelldx developed. That is a proprietary assay. If CYDY chooses to use a different lab, that lab will have to develop a new RO test for leronlimab. Those are facts.
https://www.cytodyn.com/investors/news-events...-occupancy
“They would need to use stored samples from the trial. You're starting to talk like justdafactss.”
Again, I’d place a very large wager that CYDY does not have the banked samples from the trials. This is a good question for the next CC, although it may not matter because COVID approval will make the combo BLA somewhat irrelevant.
(2)
(0)
